Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Specialty Drugs > Unithiol for Sale > Sodium2,3-dimercapto-1-propanesulfonate Pharmacy grade
Sodium2,3-dimercapto-1-propanesulfonate Pharmacy grade buy - large image1
Sodium2,3-dimercapto-1-propanesulfonate Pharmacy grade buy - image1

Sodium2,3-dimercapto-1-propanesulfonate Pharmacy grade

6 Inquiries

Unit Price: Get Latest Price
CAS No.:

4076-02-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

QINGDAO

Packaging:

2kg/2kg Cardboard Drum

Price valid (until):

2018-06-06

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Melting point 215 ° C (dec.)


    Storage conditions 2-8 ° C


    Solubility H2O: 0.1g / mL, clearMerck14, 3210BRN3734863


    CAS: 4076-02-2

    Basic Info
    Product Name:

    Unithiol

    Other Name:

    1-Propanesulfonic acid,2,3-dimercapto-,sodium salt (1:1);1-Propanesulfonic acid,2,3-dimercapto-,monosodium salt;Unithiol;Sodium 2,3-dimercaptopropanesulfonate;Sodium 2,3-dimercapto-1-propanesulfonate;Unitiol;Sodium 2,3-dimercaptopropan-1-sulfonate;DMPS;Dimaval;37260-06-3;85549-76-4;2241853-51-8

    CAS No.:

    4076-02-2

    Molecular Formula:

    C3H8O3S3.Na

    InChIKeys:

    InChIKey=UHTVFSCCUGCUPJ-UHFFFAOYSA-N

    Molecular Weight:

    210.27100

    Exact Mass:

    209.94600

    EC Number:

    223-796-3

    HScode:

    2930909090

    Categories:

    Specialty Drugs

    Characteristics
    PSA:

    143.18000

    XLogP3:

    0.84060

    Appearance:

    White powder

    Melting Point:

    235 °C

    Water Solubility:

    H2O: 0.1 g/mL, clear

    Storage Conditions:

    2-8ºC

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Location:

    No. 126 Anhui Hefei high tech Industrial Development Zone Science Road

    Hefei Lifeon Pharmaceutical Co. Ltd. was founded in 2002, is a collection of drugs (chemical, traditional Chinese medicine, biological antibody) research, production, sales as one of the joint-stock pharmaceutical enterprises. Has 3 industrial enterprises, 1 pharmaceutical business and 1 pharmaceutical retail chain enterprises, a total of more than 700 employees. Is the "high-tech enterprises", "Anhui Province innovative enterprise", "finds the provincial enterprise technology center", "the central most investment value innovation enterprise", "Anhui Province specialized special new small and medium-sized enterprise", "Hefei City drug release engineering technology center", Hefei Municipal Intellectual Property Demonstration Enterprise "; company industrial and commercial enterprises are" Anhui Province medicine quality award "," Double Excellence Award "obtain, Anhui Province A-class tax enterprise, Anhui Province Shou contract re credit units, built in Anhui Province Post Doctoral scientific research workstation; corporate unit of the pharmaceutical industry association in Anhui Province.Shares of the cubic adhere to the "innovation is the highest efficiency of the enterprise" concept, establish the osmotic pump controlled release technology, "broken broken membrane ring leaching" traditional Chinese medicine extraction and separation technology of two major technology platform, and has been fully grasp the osmotic pump controlled release drug delivery technology development and production technology, with advantage technology to promote enterprise product differentiation strategy, now is the osmotic pump product quantity most, the largest production scale of production enterprises.Cubic shares existing tablets, granules, capsules, ointment, gel, extraction of traditional Chinese medicine, oral solution, syrup, pharmaceutical raw materials and other nine GMP production lines, production and sales of main products including felodipine sustained-release tablets (II), metformin glipizide tablets, mesylate doxazosin sustained-release tablets, Liangjun oral liquid, Qi and stomach capsule, Kunning granules, compound tujing skin gel, paeonol ointment, cover cardiovascular, diabetes, gastrointestinal, urological, gynecological, tumor, skin medication multiple clinical areas. April 2013 all production lines through the national version of the GMP certification.After dozens of years of carefully building, the company has established a rich market experience of high-quality marketing team, sales network has covered 30 provinces, thousands of second class above hospital terminal, over tens of thousands of retail pharmacies, founded the promotion of new drugs, OTC terminal promotion, regional agents, and other unique characteristics of the marketing mode.Companies to create a "introduction, training, cooperation," the talent strategy. According to the company's development strategy need to introduce domestic and foreign high-end technical talents, as the development of the course leader, has been the introduction of talent, including the model to the technical field of medicine technology, biological engineering antibody, chemical synthesis and analysis of impurities and control; the Bangdai and gradient training mode, in the practice process for talent, the perfect incentive policy innovation, to establish R & D personnel growth development channel; through engagement in a variety of ways, and demand for experts in the field to establish long-term stable cooperative relations, direct participation and guide the development of the enterprise, the effective use of external resources.Cubic shares will uphold "for people with sincerity, for things to" business purpose, actively advocated "by the rulebook, according to the procedures, with a full load, is sincere, is to" corporate culture, the pursuit of efficiency as the core of the system of management.Cubic shares will play the wisdom of all staff, pragmatic innovation, accelerate development, with excellent products and services with suppliers, distributors, hospitals and retail terminals partners sincere cooperation, concentric to create community of interests, and write a new chapter in cubic shares more brilliant, and make greater contributions to the cause of human health

  • Inquiry History
    6 Inquiries
    Country Product Purchase Quantity Date Posted
    Canada

    Sodium 2, 3-Dimercapto-1-Propanesulfonate

    1 KG Feb 14, 2024
    United States

    DMPS

    100 G Jul 24, 2024
    Russia

    DMPS/UNITHIOL High Purity 99% Sodium

    1 KG Jun 17, 2024
    United States

    Dmps

    100 G Feb 29, 2024
    Vietnam

    DMPS/UNITHIOL

    5 G Jul 24, 2023
    Nigeria

    Unithiol

    10 G Dec 1, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.